APA (7th ed.) Citation

CI, F., & G, F. (1999). A phase II evaluation of clofazimine plus doxorubicin in advanced, unresectable primary hepatocellular carcinoma. Oncology, 57(3), 232. https://doi.org/10.1159/000012036

Chicago Style (17th ed.) Citation

CI, Falkson, and Falkson G. "A Phase II Evaluation of Clofazimine Plus Doxorubicin in Advanced, Unresectable Primary Hepatocellular Carcinoma." Oncology 57, no. 3 (1999): 232. https://doi.org/10.1159/000012036.

MLA (9th ed.) Citation

CI, Falkson, and Falkson G. "A Phase II Evaluation of Clofazimine Plus Doxorubicin in Advanced, Unresectable Primary Hepatocellular Carcinoma." Oncology, vol. 57, no. 3, 1999, p. 232, https://doi.org/10.1159/000012036.